RxDoctor Payments Data

Jason Cook, MD

Family Medicine · Asheville, NCNPI 1538364203

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $99,660 of the $120,296 with a category attached, or 82.8%. AbbVie accounts for 91.1% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2021 at $33,478 and has fallen 53.7% since, to $15,502 in 2025. Among family medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$120,296in general payments, 2019–2025

Across 248 payments — averaging $485.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$110K
  • Biohaven Pharmaceuticals, Inc.$10K
  • Lilly USA, LLC$146
  • Lundbeck LLC$112
  • Axsome Therapeutics, Inc.$94
  • Pfizer$79
  • plus $443 from 15 others

What the payments were for

  • Consulting fees$9,5138%
  • Speaking & faculty fees$99,66083%
  • Travel & lodging$6,5005%
  • Food & beverage$4,6234%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$120,296 in reported general payments places this provider in the 95th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$39,169
Medicare patients
141
Services billed
706

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban43$44,809
JardianceEmpagliflozin19$29,547
OzempicSemaglutide14$19,141
Aimovig AutoinjectorErenumab-Aooe20$16,625
Levothyroxine Sodium148$1,618
Duloxetine Hcl60$1,574
Tizanidine Hcl67$1,311
Gabapentin46$1,012
Amlodipine Besylate153$995
Albuterol Sulfate HfaAlbuterol Sulfate27$980
Omeprazole43$932
Nebivolol Hcl14$924
Ondansetron OdtOndansetron27$921
Oxycodone Hcl37$906
Pantoprazole Sodium62$879

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$79$44,80943 claims
Novo NordiskOzempic$39$19,14114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →